Medically Reviewed By
Dr. Aditya Singh, MBBS, MD (Pharmacology)
Reg No: MCI-654321 • Verified Medical Reviewer
Parsabiv
(etelcalcetide)
Uses, side effects, dosage information & price range
About this medicine
Parsabiv is indicated for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on haemodialysis therapy.
Common Brand Names for this Composition
The following popular commercial brand names contain etelcalcetide as their active ingredient composition:
Parsabiv
Amgen Europe B.V.
Key Information
Salt / Composition
etelcalcetide
Category
Calcium homeostasis;Anti-parathyroid agents
Manufacturer
Amgen Europe B.V.
Medical Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.
Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.